Michael Ma Email & Phone Number

• Advanced PPM Consulting, LLC is a specialized consulting firm focused on implementing innovative project, portfolio and operational excellence best practices for its pharmaceutical and life science partners• Key offerings include PPM capability building, governance and operating model, R&D roadmap per Stage Gate and portfolio prioritization, optimized path from strategy to execution, CMC and Clinical program management (Ph I to IV), alliance management, regulatory submissions, commercial launches, “Fit-for-Purpose” PPM systems and tools implementation• Previous engagements at BMS Oncology/Hematology, Vertex Cell and Genetic Therapies (VCGT) and Gates Medical Research Institute (mAbs and vaccines)

Cambridge, Massachusetts, Us

Senda is on a mission to bring life-changing treatments to patients by using nature’s codes to fully program medicines, potentially unlocking new levels of speed, breadth, and productivity in the development of advanced therapies.

Waltham, Massachusetts, Us

ElevateBio is powering transformative cell and gene therapies today and for many decades to come. Elevate right from the start - Project & Portfolio Mgt (PPM) Team is an integrated part of this transformation by leading and supporting project/program teams from discovery to clinical development across the entire Elevate portfolio!

Dublin, Dublin, Ie

• Responsible for establishing R&D governance/infrastructure and leading company’s flagship development programs (against Alzheimer’s Disease & Parkinson’s Disease) across all UNS’ global locations (US, EU and Asia)• Implemented various PPM best practices including formulation of R&D strategy, Stage-Gate framework (Project Team Guide), 1-yr/3-yr/10-yr development roadmap and portfolio prioritization• Served as Site Head for vaccine product development, platform technology/translational science, CRO/CDMO management, CMC and clinical supplies

St-Prex, Ch

• Established highly-skilled and energized Project Teams with clearly defined vision, growth strategy and operating mechanisms in meeting Ferring’s 5-year Business Plan• Implemented a comprehensive drug development methodology to conduct successful clinical trials (Phase II to IV); proactively addressed all key factors that may impact product safety, efficacy, compliance, enrollment and reimbursement • Coordinated an coherent team effort in developing a compelling value proposition and target product profile; generated “Engagement Plan” for CROs, CMOs, Key Opinion Leaders, consultants and strategic partners • Assisted Regulatory Leads in conceiving regulatory strategies for a device-drug combination asset (Modular Approach) and a prostate cancer drug label change via the 505(b)(2) route• Partnered with Business Development (BD) by leading Due Diligence Teams to evaluate external opportunities

Chicago, Us

• Provided leadership and in-depth project management expertise to 3 Clinical Program Teams concurrently in conducting Phase II to IV clinical trials as defined by Project Charter, timelines, budgets and ICH/GCP guidelines • Served as the single point of accountability for all operational aspects of the Project Teams (e.g., from strategy to execution, scenario analysis, study design/protocol, Ad Board, Investigator Meetings, ADI & Risk Logs)• As Lead Program Integrator, spearheaded a company-wide effort in assisting the Executive Team to implement GEHC’s Phase Review Discipline (PRD) customized for the pharmaceutical imaging business

• CMC, cGMP Manufacturing and Tech Transfer Experiences at Merck Vaccine Manufacturing Division and Promega Corporation (over 9 years of combined experiences)

Post-Doctoral, Molecular Biology

Post-Doctoral, Nucleic Acids Chemistry

Bs & Ph.D., Bio-Organic Chemistry